Albemarle expects net sales to jump 2.5 times by 2027
Albemarle expects net sales to grow about 2.5 times current totals by 2027.
Today the company released its strategic update. Headquartered in Charlotte, North Carolina, Albemarle (NYSE:ALB) is a global specialty chemicals company focused on lithium, bromine and refining catalysts.
"Transformational growth: expected 2027 net sales ~2.5X 2022 and adj. EBITDA >2X 2022," the company wrote in its presentation.
The company said the improved outlook will be "driven primarily by capital projects execution." The company projected its five-year net sales compound annual growth rate at about 5% and adjusted EBITDA margins 32-36% by 2027.